BACKGROUND: An ongoing HCV epidemic currently affects a growing proportion of HIV-positive men who have sex with men (MSM) in Europe. Recently in the North-Rhine region of Germany, we have observed an increase in acute HCV infections of genotype 4 (HCV-4). AIMS: To characterize the current spread of HCV-4 among German MSM using a molecular epidemiological approach. METHODS: Patient characteristics and sera were collected for HIV-positive MSM diagnosed with acute HCV-4 infections in the North-Rhine region (n=14), Hamburg (n=14), Frankfurt (n=4) and Berlin (n=4). Part of the HCV NS5B region (436 bp) was amplified, sequenced and compared with HCV-4 sequences from HIV-positive Dutch, English and French MSM (n=50) as well as unrelated HCV risk groups (n=61). RESULTS: NS5B sequences were obtained from 35/36 (97%) of German cases, all of which were HCV subtype 4d (HCV-4d). The phylogenetic analysis of HCV sequences revealed two MSM-specific HCV-4d clusters of 71 and 12 sequences. All except one of the German MSM belonged to a large MSM-specific HCV cluster containing MSM from all four different European countries. None of the HCV-4 strains circulating among injecting drug users or in HCV-4 endemic areas were part of the MSM-specific clusters. CONCLUSIONS: HCV rapidly spreads among European HIV-positive MSM through a joint international transmission network, separate from that of injecting drug users. In order to contain this epidemic, non-parenteral routes of transmission, such as unsafe sex, must be taken into consideration and prevention measures should be refocused accordingly.
BACKGROUND: An ongoing HCV epidemic currently affects a growing proportion of HIV-positive men who have sex with men (MSM) in Europe. Recently in the North-Rhine region of Germany, we have observed an increase in acute HCV infections of genotype 4 (HCV-4). AIMS: To characterize the current spread of HCV-4 among German MSM using a molecular epidemiological approach. METHODS: Patient characteristics and sera were collected for HIV-positive MSM diagnosed with acute HCV-4 infections in the North-Rhine region (n=14), Hamburg (n=14), Frankfurt (n=4) and Berlin (n=4). Part of the HCV NS5B region (436 bp) was amplified, sequenced and compared with HCV-4 sequences from HIV-positive Dutch, English and French MSM (n=50) as well as unrelated HCV risk groups (n=61). RESULTS: NS5B sequences were obtained from 35/36 (97%) of German cases, all of which were HCV subtype 4d (HCV-4d). The phylogenetic analysis of HCV sequences revealed two MSM-specific HCV-4d clusters of 71 and 12 sequences. All except one of the German MSM belonged to a large MSM-specific HCV cluster containing MSM from all four different European countries. None of the HCV-4 strains circulating among injecting drug users or in HCV-4 endemic areas were part of the MSM-specific clusters. CONCLUSIONS: HCV rapidly spreads among European HIV-positive MSM through a joint international transmission network, separate from that of injecting drug users. In order to contain this epidemic, non-parenteral routes of transmission, such as unsafe sex, must be taken into consideration and prevention measures should be refocused accordingly.
Authors: Axel J Schmidt; Luis Falcato; Benedikt Zahno; Andrea Burri; Stephan Regenass; Beat Müllhaupt; Philip Bruggmann Journal: BMC Public Health Date: 2014-01-06 Impact factor: 3.295
Authors: Natasha K Martin; Alicia Thornton; Matthew Hickman; Caroline Sabin; Mark Nelson; Graham S Cooke; Thomas C S Martin; Valerie Delpech; Murad Ruf; Huw Price; Yusef Azad; Emma C Thomson; Peter Vickerman Journal: Clin Infect Dis Date: 2016-02-16 Impact factor: 9.079
Authors: Daniel Bradshaw; Jayna Raghwani; Brendan Jacka; Rachel Sacks-Davis; Francois Lamoury; Ian Down; Garrett Prestage; Tanya L Applegate; Margaret Hellard; Joe Sasadeusz; Gregory J Dore; Oliver G Pybus; Gail V Matthews; Mark Danta Journal: PLoS One Date: 2016-09-01 Impact factor: 3.240
Authors: Karin Neukam; Pompeyo Viciana; Guillermo Ojeda-Burgos; Marcial Delgado-Fernández; María J Ríos; Juan Macías; Dolores Merino; Antonio Collado; Francisco Téllez; Juan A Pineda Journal: BMC Infect Dis Date: 2016-09-15 Impact factor: 3.090
Authors: Sophia E Schroeder; Peter Higgs; Rebecca Winter; Graham Brown; Alisa Pedrana; Margaret Hellard; Joseph Doyle; Mark Stoové Journal: J Int AIDS Soc Date: 2019-05 Impact factor: 5.396
Authors: Victor Virlogeux; Fabien Zoulim; Pascal Pugliese; Isabelle Poizot-Martin; Marc-Antoine Valantin; Lise Cuzin; Jacques Reynes; Eric Billaud; Thomas Huleux; Firouze Bani-Sadr; David Rey; Anne Frésard; Christine Jacomet; Claudine Duvivier; Antoine Cheret; Laurent Hustache-Mathieu; Bruno Hoen; André Cabié; Laurent Cotte Journal: BMC Med Date: 2017-12-18 Impact factor: 8.775
Authors: Britt Skaathun; Annick Borquez; Antonio Rivero-Juarez; Sanjay R Mehta; Francisco Tellez; Manuel Castaño-Carracedo; Dolores Merino; Rosario Palacios; Juan Macías; Antonio Rivero; Natasha K Martin Journal: BMC Infect Dis Date: 2020-08-08 Impact factor: 3.090